Pharmacy, Pharmaceutical Sciences, and Administration at University of Connecticut-Stamford

Four-year earnings of $113,478 tell the real story here—UConn-Stamford's pharmacy program appears to position students for the kind of mid-career success typical of clinical pharmacy roles. While first-year earnings are estimated at $49,444 based on national peer programs (the school's small graduate cohort means DOE suppresses actual figures), that four-year jump to $113K suggests graduates are successfully navigating licensure requirements and securing clinical positions. The $27,000 debt load—right at Connecticut's median for pharmacy programs—means students are borrowing roughly half their first-year earnings, a manageable ratio that becomes increasingly favorable as career earnings accelerate.

The caveat worth understanding: that estimated first-year figure likely captures graduates in technician roles or completing residencies before full licensure, not pharmacists in their prime earning years. The dramatic increase by year four aligns with what happens when pharmacy graduates complete their licensing requirements and move into their intended careers. For a school serving predominantly Pell-eligible students (50%) with an accessible admission profile, these outcomes suggest effective clinical training despite the lack of program-specific early-career data.

Your practical assessment comes down to whether your child can complete licensure requirements and tolerate the delayed earnings ramp-up. The debt is reasonable, the four-year earnings are strong, and the school is getting students where they need to be—but that $49K-to-$113K trajectory requires successfully clearing professional hurdles that not everyone manages on the first attempt.